CBLI Stock Price, News & Analysis

cbli NASDAQ

Company Description

CBLI (NASDAQ: cbli) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector.

cbli stock has gained 70.4% over the past year.

This page provides a comprehensive overview of cbli stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+70.43%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

CBLI (cbli) stock. Over the past 12 months, the stock has gained 70.4%.

Latest News

View All

August 31, 2021

-7.31%

Cytocom, Inc. Announces Plan to Adopt New Corporate Name "Statera BioPharma, Inc."

August 16, 2021

-7.74%

Cytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via Webcast

conferences earnings

August 16, 2021

-7.74%

Cytocom, Inc. Reports Second Quarter 2021 Financial Results

earnings

August 12, 2021

-9.17%

Cytocom, Inc. and La Jolla Institute for Immunology Announce Five-Year Research Alliance Agreement

August 11, 2021

-7.82%

Cytocom, Inc. Announces Participation at Liberty University's Empowering the Kingdom Through Business Conference

August 10, 2021

-5.12%

Cytocom, Inc. to Report Second Quarter 2021 Financial Results

conferences earnings

CBLI has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include conferences, earnings, covid-19, acquisition. View all cbli news →

SEC Filings

View All

No SEC filings available for cbli.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

cbli Company Profile & Sector Positioning

CBLI (cbli) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.